RxDoctor Payments Data

Allison Glanz

Emergency Medicine · Bowling Green, OHNPI 1386375327

Payments from drug & device makers

$1,677in general payments, 2019–2025

Across 84 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$323
  • GSK$263
  • AstraZeneca$192
  • Otsuka America Pharmaceutical, Inc.$141
  • AbbVie$126
  • Exact Sciences$106
  • plus $525 from 12 others

What the payments were for

  • Food & beverage$1,677100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,677 in reported general payments places this provider in the 95th percentile of 2,431 emergency medicine providers in Ohio.

See all emergency medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$29,503
Medicare patients
125
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$20,264
Albuterol Sulfate HfaAlbuterol Sulfate53$1,592
Atorvastatin Calcium103$867
Metoprolol Succinate69$699
Potassium Chloride39$680
Simvastatin53$680
Lisinopril92$670
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$608
Levothyroxine Sodium68$526
Pantoprazole Sodium38$472
Losartan Potassium60$384
Metformin Hcl ErMetformin Hcl24$368
Amlodipine Besylate86$364
Fluticasone Propionate29$327
Rosuvastatin Calcium18$322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$263$20,26432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,431 emergency medicine providers in Ohio.

Other emergency medicine in Bowling Green

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →